Robust Bayesian fusion of continuous segmentation maps.

Autor: Audelan B; Université Côte d'Azur, Inria, Epione project-team, Sophia Antipolis, France. Electronic address: benoit.audelan@inria.fr., Hamzaoui D; Université Côte d'Azur, Inria, Epione project-team, Sophia Antipolis, France., Montagne S; Academic Department of Radiology, Hôpital Pitié-Salpétriére, Sorbonne Université, Assistance Publique des Hôpitaux de Paris, Paris, France., Renard-Penna R; Academic Department of Radiology, Hôpital Pitié-Salpétriére, Sorbonne Université, Assistance Publique des Hôpitaux de Paris, Paris, France., Delingette H; Université Côte d'Azur, Inria, Epione project-team, Sophia Antipolis, France.

Publikováno v: Medical image analysis [Med Image Anal] 2022 May; Vol. 78, pp. 102398. Date of Electronic Publication: 2022 Mar 02.

In-house Implementation of Tumor Mutational Burden Testing to Predict Durable Clinical Benefit in Non-small Cell Lung Cancer and Melanoma Patients.

Autor: Heeke S; Université Côte d'Azur, 06000 Nice, France.; Team 4, Institute for Research on Cancer and Aging Nice (IRCAN), Institut de la Santé et de le Recherche Médicale (INSERM) U1081/CNRS 7284, 06107 Nice, France.; Laboratory of Clinical and Experimental Pathology, Biobank BB-0033-00025, Centre Hospitalier Universitaire de Nice, 06000 Nice, France.; FHU OncoAge, Pasteur Hospital, 06000 Nice, France., Benzaquen J; Université Côte d'Azur, 06000 Nice, France.; Team 4, Institute for Research on Cancer and Aging Nice (IRCAN), Institut de la Santé et de le Recherche Médicale (INSERM) U1081/CNRS 7284, 06107 Nice, France.; Department of Pulmonology and Thoracic Oncology, Centre Hospitalier Universitaire de Nice, 06000 Nice, France., Long-Mira E; Université Côte d'Azur, 06000 Nice, France.; Team 4, Institute for Research on Cancer and Aging Nice (IRCAN), Institut de la Santé et de le Recherche Médicale (INSERM) U1081/CNRS 7284, 06107 Nice, France.; Laboratory of Clinical and Experimental Pathology, Biobank BB-0033-00025, Centre Hospitalier Universitaire de Nice, 06000 Nice, France.; FHU OncoAge, Pasteur Hospital, 06000 Nice, France., Audelan B; Université Côte d'Azur, 06000 Nice, France.; Epione Team, Inria, Sophia Antipolis, 06902 Valbonne, France., Lespinet V; Université Côte d'Azur, 06000 Nice, France.; Laboratory of Clinical and Experimental Pathology, Biobank BB-0033-00025, Centre Hospitalier Universitaire de Nice, 06000 Nice, France., Bordone O; Université Côte d'Azur, 06000 Nice, France.; Laboratory of Clinical and Experimental Pathology, Biobank BB-0033-00025, Centre Hospitalier Universitaire de Nice, 06000 Nice, France., Lalvée S; Université Côte d'Azur, 06000 Nice, France.; Laboratory of Clinical and Experimental Pathology, Biobank BB-0033-00025, Centre Hospitalier Universitaire de Nice, 06000 Nice, France., Zahaf K; Université Côte d'Azur, 06000 Nice, France.; Laboratory of Clinical and Experimental Pathology, Biobank BB-0033-00025, Centre Hospitalier Universitaire de Nice, 06000 Nice, France., Poudenx M; Université Côte d'Azur, 06000 Nice, France.; Department of Oncology, Antoine Lacassagne Comprehensive Cancer Center, 06200 Nice, France., Humbert O; Université Côte d'Azur, 06000 Nice, France.; Department of Nuclear Medicine, Antoine Lacassagne Comprehensive Cancer Center, 06200 Nice, France., Montaudié H; Université Côte d'Azur, 06000 Nice, France.; FHU OncoAge, Pasteur Hospital, 06000 Nice, France.; Department of Dermatology, Archet II Hospital, Centre Hospitalier Universitaire de Nice, 06000 Nice, France., Dugourd PM; Université Côte d'Azur, 06000 Nice, France.; Department of Dermatology, Archet II Hospital, Centre Hospitalier Universitaire de Nice, 06000 Nice, France., Chassang M; Université Côte d'Azur, 06000 Nice, France.; Department of Radiology, Archet 2 Hospital, Centre Hospitalier Universitaire de Nice, 06000 Nice, France., Passeron T; Université Côte d'Azur, 06000 Nice, France.; FHU OncoAge, Pasteur Hospital, 06000 Nice, France.; Department of Dermatology, Archet II Hospital, Centre Hospitalier Universitaire de Nice, 06000 Nice, France.; Centre Méditerranéen de Médecine Moléculaire (C3M), Institut de la Santé et de le Recherche Médicale (INSERM) U1065, 06204 Nice, France., Delingette H; Université Côte d'Azur, 06000 Nice, France.; FHU OncoAge, Pasteur Hospital, 06000 Nice, France.; Epione Team, Inria, Sophia Antipolis, 06902 Valbonne, France., Marquette CH; Université Côte d'Azur, 06000 Nice, France.; Team 4, Institute for Research on Cancer and Aging Nice (IRCAN), Institut de la Santé et de le Recherche Médicale (INSERM) U1081/CNRS 7284, 06107 Nice, France.; Laboratory of Clinical and Experimental Pathology, Biobank BB-0033-00025, Centre Hospitalier Universitaire de Nice, 06000 Nice, France.; FHU OncoAge, Pasteur Hospital, 06000 Nice, France.; Department of Pulmonology and Thoracic Oncology, Centre Hospitalier Universitaire de Nice, 06000 Nice, France., Hofman V; Université Côte d'Azur, 06000 Nice, France.; Team 4, Institute for Research on Cancer and Aging Nice (IRCAN), Institut de la Santé et de le Recherche Médicale (INSERM) U1081/CNRS 7284, 06107 Nice, France.; Laboratory of Clinical and Experimental Pathology, Biobank BB-0033-00025, Centre Hospitalier Universitaire de Nice, 06000 Nice, France.; FHU OncoAge, Pasteur Hospital, 06000 Nice, France., Stenzinger A; Institute of Pathology, University Hospital Heidelberg, 69120 Heidelberg, Germany.; Center for Personalized Oncology (DKFZ-HIPO), Deutsches Krebsforschungszentrum (DKFZ), 69120 Heidelberg, Germany., Ilié M; Université Côte d'Azur, 06000 Nice, France.; Team 4, Institute for Research on Cancer and Aging Nice (IRCAN), Institut de la Santé et de le Recherche Médicale (INSERM) U1081/CNRS 7284, 06107 Nice, France.; Laboratory of Clinical and Experimental Pathology, Biobank BB-0033-00025, Centre Hospitalier Universitaire de Nice, 06000 Nice, France.; FHU OncoAge, Pasteur Hospital, 06000 Nice, France., Hofman P; Université Côte d'Azur, 06000 Nice, France. hofman.p@chu-nice.fr.; Team 4, Institute for Research on Cancer and Aging Nice (IRCAN), Institut de la Santé et de le Recherche Médicale (INSERM) U1081/CNRS 7284, 06107 Nice, France. hofman.p@chu-nice.fr.; Laboratory of Clinical and Experimental Pathology, Biobank BB-0033-00025, Centre Hospitalier Universitaire de Nice, 06000 Nice, France. hofman.p@chu-nice.fr.; FHU OncoAge, Pasteur Hospital, 06000 Nice, France. hofman.p@chu-nice.fr.

Publikováno v: Cancers [Cancers (Basel)] 2019 Aug 29; Vol. 11 (9). Date of Electronic Publication: 2019 Aug 29.

Mutations in KMT2C , BCOR and KDM5C Predict Response to Immune Checkpoint Blockade Therapy in Non-Small Cell Lung Cancer.

Autor: Liu, Dingxie¹ (AUTHOR) dliu@bluewater-biotech.com, Benzaquen, Jonathan² (AUTHOR) benzaquen.j@chu-nice.fr, Morris, Luc G. T.³ (AUTHOR) morrisl@mskcc.org, Ilié, Marius² (AUTHOR) ilie.m@chu-nice.fr, Hofman, Paul^4,5,6 (AUTHOR) dliu@bluewater-biotech.com

Publikováno v: Cancers. Jun2022, Vol. 14 Issue 11, p2816-2816. 16p.

Predictive value of tumor mutational burden for immunotherapy in non-small cell lung cancer: A systematic review and meta-analysis.

Autor: Meng, Guangxian¹ (AUTHOR), Liu, Xiaowei¹ (AUTHOR), Ma, Tian¹ (AUTHOR), Lv, Desheng¹ (AUTHOR), Sun, Ge¹ (AUTHOR) sunge86@126.com

Publikováno v: PLoS ONE. 2/3/2022, Vol. 17 Issue 2, p1-19. 19p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.